Bluff Joanne E, Brown Nicola J, Reed Malcolm W R, Staton Carolyn A
Microcirculation Research Group, Academic Unit of Surgical Oncology, School of Medicine and Biomedical Sciences, Beech Hill Road, Sheffield S10 2RX, UK.
Breast Cancer Res. 2008;10(2):204. doi: 10.1186/bcr1871. Epub 2008 Mar 17.
Tissue factor, the primary initiator of the coagulation cascade, maintains vascular integrity in response to injury. It is now recognised that, in addition to the role as a procoagulant activator, tissue factor participates in many tumour-related processes that contribute to malignant disease progression. The present review details the recent evidence supporting a role for tissue factor in tumour haemostasis, angiogenesis, metastasis and malignant cell survival. Furthermore, future research directions are discussed that may enhance our understanding of the role and regulation of this protein, which could ultimately lead to the innovative design and development of new anticancer therapies.
组织因子是凝血级联反应的主要启动因子,可在损伤时维持血管完整性。现在人们认识到,除了作为促凝血激活剂的作用外,组织因子还参与许多与肿瘤相关的过程,这些过程促进恶性疾病的进展。本综述详细介绍了支持组织因子在肿瘤止血、血管生成、转移和恶性细胞存活中发挥作用的最新证据。此外,还讨论了未来的研究方向,这些方向可能会增进我们对该蛋白的作用和调节的理解,最终可能会带来新的抗癌疗法的创新设计和开发。